Why is it rising? Why is it falling? Some explanations on the unusual variations which affect shares during the day’s session on European markets. Only when they are reliable and documented: we avoid telling nonsense as much as possible. Variations are taken at the time of writing the article.
Rising
- OSE Immuno (+9%): the French biotech reported this morning that “clinically convincing and statistically significant results” in its phase II study evaluating the Anti-IL7R antibody Lusvertikimab in ulcerative colitis. The primary endpoint was met, as well as the secondary endpoints.
- Schweiter (+7%): ZKB moves from market performance to outperformance, with a price target set at CHF 415.
- Bachem (+6%): JP Morgan starts overweight monitoring with a price target of 86 CHF.
- Burberry (+6%): the specialized media Miss Tweed reported Moncler’s interest in the British group.
- EssilorLuxottica (+4%): Meta’s entry into the capital is becoming clearer… Information obtained by BFM Business suggests that the American group will take 4 to 5% of the capital, which would fit with an investment of 4 to 5 billion euros. euros, already mentioned, given a capitalization close to €100 billion.
- Volvo Car (+3%): the manufacturer saw its global sales increase by 3% in October, thanks to a 40% increase in demand for electric and plug-in hybrid models in Europe.
Declining
- Samhällsbyggnadsbolaget (-25%): the financial newspaper Dagens industri recommended selling the real estate company in its “Stock of the Week” section. In its analysis, the newspaper goes so far as to wonder whether the company will survive next year.
- DFDS (-3%): the group has issued a warning. SEB Bank has maintained its “hold” recommendation but cuts its price target from 175 to 140 DKK.
- BE Semiconductor (-3%): the sector is in turmoil in Europe after Friday’s rebound. The stock has lost 10% in one month.
- Ryanair (-2.5%): half-year results are down. The company has also revised its medium-term traffic projections downward due to Boeing’s delays.
Related News :